A new clinical study shows that an inhibitor of Fas ligand (FasL), also called CD95 ligand (CD95L), led to a faster recovery ...
In an increasingly digital world, healthcare and public health systems are advancing through technology that ... supporting ...
Two open-access reviews by a renowned neonatal immunologist have highlighted the uniqueness of the developing infant immune ...
Sea's novel synthetic molecules act at the neurotransmitter glutamate pathway on two clinically validated targets in the central nervous system, "the CNS"Two potent, selective, pre-clinical stage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback